title: Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.
abstract: Despite advances in medical device fabrication and antimicrobial treatment therapies, fungal-bacterial polymicrobial peritonitis remains a serious complication for surgery patients, those on peritoneal dialysis, and the critically ill. Using a murine model of peritonitis, we have demonstrated that monomicrobial infection with Candida albicans or Staphylococcus aureus is nonlethal. However, coinfection with these same doses leads to a 40% mortality rate and increased microbial burden in the spleen and kidney by day 1 postinfection. Using a multiplex enzyme-linked immunosorbent assay, we have also identified a unique subset of innate proinflammatory cytokines (interleukin-6, granulocyte colony-stimulating factor, keratinocyte chemoattractant, monocyte chemoattractant protein-1, and macrophage inflammatory protein-1α) that are significantly increased during polymicrobial versus monomicrobial peritonitis, leading to increased inflammatory infiltrate into the peritoneum and target organs. Treatment of coinfected mice with the cyclooxygenase (COX) inhibitor indomethacin reduces the infectious burden, proinflammatory cytokine production, and inflammatory infiltrate while simultaneously preventing any mortality. Further experiments demonstrated that the immunomodulatory eicosanoid prostaglandin E2 (PGE2) is synergistically increased during coinfection compared to monomicrobial infection; indomethacin treatment also decreased elevated PGE2 levels. Furthermore, addition of exogenous PGE2 into the peritoneal cavity during infection overrode the protection provided by indomethacin and restored the increased mortality and microbial burden. Importantly, these studies highlight the ability of fungal-bacterial coinfection to modulate innate inflammatory events with devastating consequences to the host.
authors.affiliation: Department of Oral and Craniofacial Biology, Dental School, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
authors.forename: Brian M
authors.initials: BM
authors.lastname: Peters
authors.forename: Mairi C
authors.initials: MC
authors.lastname: Noverr
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002176:Candida albicans; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D060085:Coinfection; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D007113:Immunity, Innate; D007213:Indomethacin / Q000627:therapeutic use; D007668:Kidney / Q000382:microbiology; D055624:Methicillin-Resistant Staphylococcus aureus; D051379:Mice; D010538:Peritonitis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D013154:Spleen / Q000382:microbiology; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin
references.citation: Hippokratia. 2011 Jan;15(Suppl 1):16-21
references.pmid: 21897753
references.citation: PLoS One. 2008 Oct 03;3(10):e3326
references.pmid: 18833331
references.citation: Infect Immun. 2000 Oct;68(10):5953-9
references.pmid: 10992507
references.citation: Acad Emerg Med. 2010 Oct;17(10):1072-9
references.pmid: 21040108
references.citation: Surgery. 2007 Mar;141(3):403-10
references.pmid: 17349853
references.citation: Am J Kidney Dis. 1995 Mar;25(3):461-4
references.pmid: 7872325
references.citation: J Invest Surg. 2008 Nov-Dec;21(6):330-9
references.pmid: 19160143
references.citation: Braz J Infect Dis. 2004 Apr;8(2):118-25
references.pmid: 15361989
references.citation: Am J Med. 2002 Dec 15;113(9):728-33
references.pmid: 12517362
references.citation: J Histochem Cytochem. 1982 May;30(5):466-70
references.pmid: 6804558
references.citation: Infect Immun. 2004 Sep;72(9):4996-5003
references.pmid: 15321991
references.citation: FEMS Microbiol Lett. 2009 Oct;299(1):1-8
references.pmid: 19552706
references.citation: J Leukoc Biol. 2007 Jan;81(1):137-43
references.pmid: 17020929
references.citation: Intensive Care Med. 1996 Nov;22(11):1169-75
references.pmid: 9120108
references.citation: PLoS One. 2009 Jul 29;4(7):e6420
references.pmid: 19641609
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3429-34
references.pmid: 15728393
references.citation: J Leukoc Biol. 2008 Jan;83(1):64-70
references.pmid: 17884993
references.citation: J Immunol. 2005 Aug 15;175(4):2606-12
references.pmid: 16081835
references.citation: Appl Environ Microbiol. 1991 Jan;57(1):51-6
references.pmid: 16348404
references.citation: Immunopharmacol Immunotoxicol. 1995 May;17(2):311-21
references.pmid: 7650293
references.citation: Sci Rep. 2012;2:786
references.pmid: 23139859
references.citation: World J Surg. 2011 Dec;35(12):2650-9
references.pmid: 21976010
references.citation: Protein Sci. 1997 Aug;6(8):1643-52
references.pmid: 9260277
references.citation: Shock. 1999 Aug;12(2):118-26
references.pmid: 10446892
references.citation: Blood. 1995 Feb 1;85(3):799-803
references.pmid: 7530510
references.citation: J Immunol. 2006 Jul 1;177(1):681-93
references.pmid: 16785567
references.citation: Am J Kidney Dis. 2011 Sep;58(3):429-36
references.pmid: 21601333
references.citation: Int Immunol. 2010 Nov;22(11):889-95
references.pmid: 21059767
references.citation: Growth Factors. 2005 Mar;23(1):33-41
references.pmid: 16019425
references.citation: Antimicrob Agents Chemother. 2009 Sep;53(9):3914-22
references.pmid: 19564370
references.citation: Kidney Int. 1998 Dec;54(6):2170-83
references.pmid: 9853284
references.citation: Infect Immun. 2001 Aug;69(8):5046-55
references.pmid: 11447185
references.citation: PLoS Pathog. 2009 Dec;5(12):e1000703
references.pmid: 20041174
references.citation: J Exp Med. 1996 Sep 1;184(3):883-91
references.pmid: 9064348
references.citation: Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Nov;269(3):377-86
references.pmid: 3064497
references.citation: APMIS. 2011 Feb;119(2):155-63
references.pmid: 21208283
references.citation: J Immunol. 2004 Jul 1;173(1):559-65
references.pmid: 15210817
references.citation: Clin Microbiol Rev. 2012 Jan;25(1):193-213
references.pmid: 22232376
references.citation: Appl Environ Microbiol. 2005 May;71(5):2663-76
references.pmid: 15870358
references.citation: Nature. 2012 Oct 4;490(7418):107-11
references.pmid: 22902502
references.citation: J Immunol. 1998 Oct 1;161(7):3746-52
references.pmid: 9759900
references.citation: Semin Respir Crit Care Med. 2011 Apr;32(2):195-205
references.pmid: 21506056
references.citation: J Antimicrob Chemother. 2007 Nov;60(5):1051-9
references.pmid: 17848374
references.citation: Microbes Infect. 2000 Oct;2(12):1425-30
references.pmid: 11099928
references.citation: Am J Med. 1999 Dec 13;107(6A):11S-16S; discussion 16S-17S
references.pmid: 10628589
references.citation: FEMS Immunol Med Microbiol. 2010 Aug;59(3):493-503
references.pmid: 20608978
references.citation: J Med Microbiol. 2006 Aug;55(Pt 8):999-1008
references.pmid: 16849719
references.citation: Infect Immun. 1983 Oct;42(1):285-92
references.pmid: 6352497
references.citation: Microb Pathog. 2007 Nov-Dec;43(5-6):208-16
references.pmid: 17689046
references.citation: Proc Natl Acad Sci U S A. 1996 May 14;93(10):4885-90
references.pmid: 8643498
references.citation: J Exp Med. 2006 Apr 17;203(4):941-51
references.pmid: 16567391
references.citation: J Exp Med. 2000 May 15;191(10):1661-74
references.pmid: 10811860
references.citation: PLoS Pathog. 2008 Oct;4(10):e1000184
references.pmid: 18949036
references.citation: Trends Microbiol. 2011 Apr;19(4):198-208
references.pmid: 21296575
references.citation: Surg Endosc. 1999 Aug;13(8):801-3
references.pmid: 10430689
references.citation: J Biol Chem. 1999 Apr 23;274(17):11660-6
references.pmid: 10206978
references.citation: Hepatogastroenterology. 1997 Jul-Aug;44(16):927-36
references.pmid: 9261580
references.citation: J Clin Invest. 2002 Nov;110(10):1461-71
references.pmid: 12438444
references.citation: Am J Kidney Dis. 2000 Nov;36(5):1000-8
references.pmid: 11054357
references.citation: Shock. 2011 Oct;36(4):396-401
references.pmid: 21701414
references.citation: Infect Immun. 1982 Dec;38(3):921-4
references.pmid: 7152678
references.citation: J Immunol. 2003 Jan 1;170(1):503-7
references.pmid: 12496437
references.citation: Clin Infect Dis. 2000 Dec;31(6):1338-42
references.pmid: 11095999
references.citation: Trends Microbiol. 2008 Aug;16(8):361-9
references.pmid: 18585915
references.citation: Am J Kidney Dis. 2010 Jan;55(1):121-31
references.pmid: 19932543